Dual-Action Analgesia and Complex Oncology Pain Management Applications
Rising cancer incidence, expanding clinical adoption of NMDA-targeting analgesics, and the need for cost-effective pain management options in palliative care are driving clinical utilization within the Methadone Market. Methadone possesses unique pharmacological properties among opioids, acting both as a mu-opioid receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist. This...
0 Commenti 0 condivisioni 105 Views 0 Anteprima